ExodusPoint Capital Management, LP - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 168 filers reported holding CLOVIS ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q1 2022$313,000
+58.9%
155,020
+112.7%
0.00%
+100.0%
Q4 2021$197,000
-45.0%
72,868
-9.1%
0.00%
-60.0%
Q3 2021$358,000
-47.7%
80,202
-32.1%
0.01%
-37.5%
Q2 2021$685,000
+254.9%
118,079
+256.0%
0.01%
+100.0%
Q3 2020$193,000
-25.8%
33,169
-14.0%
0.00%
-42.9%
Q2 2020$260,000
+101.6%
38,562
+210.6%
0.01%
+250.0%
Q4 2019$129,00012,4150.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 150,000$1,564,0004.60%
Healthcare Value Capital, LLC 100,000$1,043,0003.07%
Palo Alto Investors LP 5,056,286$52,712,0002.90%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,328,200$13,848,0001.53%
Ikarian Capital, LLC 513,700$5,355,0000.87%
Pinz Capital Management, LP 207,800$2,166,0000.79%
Leap Investments LP 146,300$1,525,0000.72%
Elk Creek Partners, LLC 574,616$5,990,0000.69%
SECTOR GAMMA AS 408,625$4,260,0000.68%
Artal Group S.A. 1,000,000$10,425,0000.40%
View complete list of CLOVIS ONCOLOGY INC shareholders